Riffyn Featured in Two Gartner® Hype Cycle™ Categories — Bioprocessing Informatics and Enterprise Laboratory Informatics
Riffyn Identified in 2021 Gartner® Hype Cycle™ for Life Science Manufacturing, Quality and Supply Chain report under two Categories — Bioprocessing Informatics and Enterprise Laboratory Informatics
The leading provider of Intelligent Process Development software in biopharma and biotech was recognized as a Sample Vendor in the 2021 Gartner Hype Cycle for Life Science Manufacturing, Quality and Supply Chain for two categories-Bioprocessing Informatics and Enterprise Laboratory Informatics.
OAKLAND, Calif.--(BUSINESS WIRE) —Riffyn, the leading provider of SaaS for Intelligent Process Development, today announced that it has been recognized in 2021 Gartner Hype Cycle for Life Science Manufacturing, Quality and Supply Chain.1 Riffyn was acknowledged under two categories — Bioprocessing Informatics and Enterprise Laboratory Informatics. Per this Gartner report, bioprocessing informatics tools bring business impact as they “create process intelligence using analytics across laboratory, scientific and formulation data”. Further this report states that they, “predict yields, purities and costs, by arranging and analyzing ML-enabled data.”
The COVID-19 pandemic has catapulted the criticality of data in life sciences and healthcare industries. Companies have recognized that traditional ways of organizing data for decision-making will not suffice in the age of AI. At a growth rate of 44%, the machine learning technologies market is projected to reach USD $8.8 billion by 2022. Companies are reengineering the way they capture, store, and process data.
Riffyn, which pioneered the emerging field of Intelligent Process Development, is utilizing its cloud software, Riffyn Nexus®, to propel scientific discovery research into development. Its SaaS, backed by 7 patents, helps R&D teams improve processes quicker and bring products to market faster by making massive experiment data ML-ready for deep analytics.
“The intelligence gained from deep learning enables scientists to spot anomalies real-time and improve faster with more precision than their competitors who, in the meantime, are bogged down by data cleaning, data linking, and reconciling naming conventions,” said Riffyn CEO Tim Gardner. “Riffyn Nexus already supports digital transformation at 3 of the top 6 largest biopharma companies and 3 of the top 5 largest industrial biotech companies. Our customers create life-changing products — from vaccines and medicines to sustainable materials and next-gen food products.
Gartner, “Hype Cycle for Life Science Manufacturing, Quality and Supply Chain,” Michael Shanler, Andrew Stevens, Rick Franzosa, July 20, 2021.
GARTNER and Hype Cycle are a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's Research and Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Riffyn enables scientific R&D teams to bring products to market faster. The Intelligent Process Development platform Riffyn Nexus® shapes data from thousands of experiments into formats ready for machine learning and deep analytics. To learn more about how Riffyn is enabling R&D teams to double their discovery-to-development speed visit riffyn.com or follow us on LinkedIn.
Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of traditional scientific data systems — delivering results that are always ready for machine learning.